Insite

  • BC-CfE’s research laboratory produced techniques to measure the amount and impact of different levels of adherence to HIV therapies.
  • BC-CfE initiates the Scientific Evaluation of North America’s first supervised injection facility – Insite.
  • BC-CfE initiates a large cohort study of street-involved youth to examine their health-related needs.

Leave a Reply

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025